These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7700900)

  • 21. Expansion and activation of human natural killer cells as therapy for autologous transplantation.
    Miller JS; Verfaillie C; McGlave P
    Prog Clin Biol Res; 1994; 389():39-45. PubMed ID: 7700914
    [No Abstract]   [Full Text] [Related]  

  • 22. Antisense oligodeoxynucleotides for the treatment of chronic myelogenous leukemia: are they still a promise?
    de Fabritiis P; Calabretta B
    Haematologica; 1995; 80(4):295-9. PubMed ID: 7590496
    [No Abstract]   [Full Text] [Related]  

  • 23. Typical chronic myelogenous leukemia with e19a2 BCR/ABL transcript. Report of two cases.
    Martínez-López J; Ayala R; Albizua Q
    Haematologica; 2002 Aug; 87(8):ELT35. PubMed ID: 12161380
    [No Abstract]   [Full Text] [Related]  

  • 24. Chronic myeloid leukemia.
    Sawyers CL
    N Engl J Med; 1999 Apr; 340(17):1330-40. PubMed ID: 10219069
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of chronic myelogenous leukemia (CML) with c-myb antisense oligodeoxynucleotides.
    Gewirtz AM
    Bone Marrow Transplant; 1994; 14 Suppl 3():S57-61. PubMed ID: 7697011
    [No Abstract]   [Full Text] [Related]  

  • 26. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
    Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. bcr/abl chimeric transcript in patients in remission after marrow transplantation for chronic myeloid leukemia: higher frequency of detection and slower clearance in patients grafted in advanced disease as compared to patients grafted in chronic phase.
    Frassoni F; Martinelli G; Saglio G; Sessarego M; Podestà M; Piaggio G; Farabegoli P; Zaccaria A; Testoni N; Remiddi C
    Bone Marrow Transplant; 1995 Oct; 16(4):595-601. PubMed ID: 8528178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of retroviral transduction in chronic myelogenous leukemia.
    Claxton D; Suh SP; Filaccio M; Ellerson D; Gaozza E; Andersson B; Brenner M; Reading C; Feinberg A; Moen R
    Hum Gene Ther; 1991; 2(4):317-21. PubMed ID: 1665348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term culture of autologous bone marrow for marrow reconstitution following high-dose chemotherapy. Purging with tumor surface antigen directed human-human monoclonal antibody.
    Alonso K; Medenica R; Morehead G
    Prog Clin Biol Res; 1994; 389():111-8. PubMed ID: 7700892
    [No Abstract]   [Full Text] [Related]  

  • 30. [Using real-time polymerase chain reaction to quantitate bcr-abl mRNA].
    Liu JX; Liu JL; Wang GJ
    Ai Zheng; 2006 Nov; 25(11):1447-9. PubMed ID: 17094919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical value of quantitative long-term assessment of bcr-abl chimeric transcript in chronic myelogenous leukemia patients after allogeneic bone marrow transplantation.
    Martinelli G; Montefusco V; Testoni N; Amabile M; Saglio G; Ottaviani E; Terragna C; Bonifazi F; Rosti G; Bandini G; Tura S
    Haematologica; 2000 Jun; 85(6):653-8. PubMed ID: 10870124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional activation of human LIM-HOX gene hLH-2 in chronic myelogenous leukemia is due to a cis-acting effect of Bcr-Abl.
    Wu HK; Minden MD
    Biochem Biophys Res Commun; 1997 May; 234(3):742-7. PubMed ID: 9175786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of different ribozymes for efficient and specific cleavage of BCR/ABL related mRNAs.
    Lange W; Daskalakis M; Finke J; Dölken G
    FEBS Lett; 1994 Jan; 338(2):175-8. PubMed ID: 8307177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction.
    Mahon FX; Ripoche J; Pigeonnier V; Jazwiec B; Pigneux A; Moreau JF; Reiffers J
    Exp Hematol; 1995 Dec; 23(14):1606-11. PubMed ID: 8542954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ex vivo effects associated with the expression of a bcr-abl-specific ribozyme in a CML cell line.
    Wright LA; Milliken S; Biggs JC; Kearney P
    Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):15-23. PubMed ID: 9512092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autologous bone marrow transplantation for acute leukemia using ferromagnetic microparticles and monoclonal antibody-purged marrows: demonstration of effectiveness by polymerase chain reaction.
    Bieva C; Martiat P; Ferster A; Sariban E; Kedar A; Erdos G; Bron D; Debusscher L; Stryckmans P
    Prog Clin Biol Res; 1992; 377():197-204. PubMed ID: 1438416
    [No Abstract]   [Full Text] [Related]  

  • 37. BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phase.
    de Fabritiis P; Petti MC; Montefusco E; De Propris MS; Sala R; Bellucci R; Mancini M; Lisci A; Bonetto F; Geiser T; Calabretta B; Mandelli F
    Blood; 1998 May; 91(9):3156-62. PubMed ID: 9558370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bone marrow transplantation].
    Miyamura K; Morishima Y
    Rinsho Byori; 1991 Jul; Suppl 90():23-34. PubMed ID: 1920852
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic myelogenous leukemia--the unfolding saga.
    Goldman JM; Grosveld G; Baltimore D; Gale RP
    Leukemia; 1990 Mar; 4(3):163-7. PubMed ID: 2179637
    [No Abstract]   [Full Text] [Related]  

  • 40. Molecular biology to check patients treated for CML.
    Saglio G; Zaccaria A; Tassinari A; Rosti G; Lo Coco F; Diverio D; Rege Cambrin G; Scaravaglio P; Rosso C; Guerrasio A
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():98-100. PubMed ID: 2627627
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.